MRNA Jul 2024 155.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

11.95

+0.30

(+2.58%)

As of 01:39PM EDT. Market open.

Loading interactive chart…

Barrons.com
New Covid Boosters Get a Thumbs-Up From FDA. Vaccine Stocks Are Wavering.
Drugmakers are aiming to launch this year’s shots by the beginning of September but have been waiting on the FDA to decide which strain of the virus to target. At their meeting on Wednesday, the FDA’s advisers nevertheless recommended that this year’s shots target JN.1, saying they expect a JN.1 shot to offer sufficient protection against the strain’s descendants.
Zacks
Halozyme Therapeutics (HALO) Up 8.7% Since Last Earnings Report: Can It Continue?
Halozyme Therapeutics (HALO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
5 Stocks Propelling S&P 500 to 25th Record High
The S&P 500 touches a record high for the 25th time this year, powered by technology stocks. We have highlighted five technology stocks, HPE, MRNA, AVGO, MU and LRCX, leading the way higher in the latest trading session.